A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model

Condition:   Healthy Interventions:   Drug: SAGE-217 high dose;   Drug: Placebo;   Drug: SAGE-217 low dose Sponsor:   Sage Therapeutics Not yet recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Insomnia | Study